COGT News and Press, Cogent Biosciences Inc Com From 06/13/22

MicroStrategy (MSTR) -25% as crypto market cap sinks below $1T. Astra Space (ASTR) -25% after latest mission failure. Qutoutiao (QTT) -21%. Marathon Digital Holdings (MARA) -17% as crypto market cap sinks below $1T. Bitfarms (BITF) -17% as cry...

Cogent Biosciences (NASDAQ:COGT) commenced an underwritten public offering of $125M of shares; underwriters granted 30-day option to purchase up to an additional $18.75M of shares. Net proceeds to be used for development, regulatory and commercial preparation activities relating to bezuclasti...

CAMBRIDGE, Mass. and BOULDER, Colo., June 13, 2022 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that it has commenced an underwritten public offering of $1...

Stocks plunged on Friday, as new consumer price data stoked fears that mounting inflation will force the Federal Reserve into even more aggressive interest rate hikes. With investors worried that a Fed-triggered recession is on the horizon, the Nasdaq dropped 3.5%, while the S&P 500 retre...

The following slide deck was published by Cogent Biosciences, Inc. in conjunction with this event. For further details see: Cogent Biosciences (COGT) Presents at EHA 2022 Congress

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today’s market is downright nasty. At one point this morning, there were zero  Dow  components trading in the green. Accordingly, looking at winners such as  Cogent Biosciences  (NASDAQ: COGT ...

Gainers: Cogent Biosciences (COGT) +89%. Redbox Entertainment (RDBX) +48%. Alpha Tau Medical (DRTS) +23%. Bright Green Corporation (BGXX) +17%. Aridis Pharmaceuticals (ARDS) +18%. Wah Fu Education Group (WAFU) +14%. Powerbridge Technologies (PBTS) +12%. Hycroft Mining Holding Corporation (HYM...

Gainers: Cogent Biosciences (COGT) +56%. IO Biotech (IOBT) +9%. Celularity (CELU) +6%. PolarityTE (PTE) +6%. Aridis Pharmaceuticals (ARDS) +5%. Losers: Fulcrum Therapeutics (FULC) -48%. Caribou Biosciences (CRBU) -33%. DBV Technologies (DBVT) -18%. Card...

Cogent Biosciences (NASDAQ:COGT) stock rose ~5% premarket June 10 after the company reported initial data from an ongoing phase 2 trial of bezuclastinib in patients with advanced systemic mastocytosis (AdvSM). Systemic Mastocytosis is a rare disorder in which a type of white blood cell c...

All patients treated with bezuclastinib achieved ≥ 50% reduction in serum tryptase, with a median reduction of 89%, regardless of prior KIT D816V inhibitor treatment All bone marrow biopsy-assessed patients achieved ≥ 50% bone marrow mast cell reduction&#...